Volume 26, Issue 11
Research Article

Tutorial in biostatistics: competing risks and multi‐state models

H. Putter

Corresponding Author

E-mail address: h.putter@lumc.nl

Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands

Contributed equally to this tutorial.

Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, P.O. Box 9604, 2300 RC, Leiden, The NetherlandsSearch for more papers by this author
M. Fiocco

Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands

Search for more papers by this author
R. B. Geskus

Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands

Amsterdam Health Service, Amsterdam, The Netherlands

Academic Medical Center, Amsterdam, The Netherlands

Contributed equally to this tutorial.

Search for more papers by this author
First published: 10 October 2006
Citations: 1,057

Abstract

Standard survival data measure the time span from some time origin until the occurrence of one type of event. If several types of events occur, a model describing progression to each of these competing risks is needed. Multi‐state models generalize competing risks models by also describing transitions to intermediate events. Methods to analyze such models have been developed over the last two decades. Fortunately, most of the analyzes can be performed within the standard statistical packages, but may require some extra effort with respect to data preparation and programming. This tutorial aims to review statistical methods for the analysis of competing risks and multi‐state models. Although some conceptual issues are covered, the emphasis is on practical issues like data preparation, estimation of the effect of covariates, and estimation of cumulative incidence functions and state and transition probabilities. Examples of analysis with standard software are shown. Copyright © 2006 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 1057

  • Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study, BMC Medicine, 10.1186/s12916-019-1474-7, 18, 1, (2020).
  • Validating patient prioritization in the 2018 Revised United Network for Organ Sharing Heart Allocation System: A single‐center experience, Clinical Transplantation, 10.1111/ctr.13816, 34, 3, (2020).
  • Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy, Radiotherapy and Oncology, 10.1016/j.radonc.2020.04.012, (2020).
  • Statement on Methods in Sport Injury Research From the First METHODS MATTER Meeting, Copenhagen, 2019, Journal of Orthopaedic & Sports Physical Therapy, 10.2519/jospt.2020.9876, 50, 5, (226-233), (2020).
  • Model-free feature screening for ultra-high dimensional competing risks data, Statistics & Probability Letters, 10.1016/j.spl.2020.108815, 164, (108815), (2020).
  • Death and long-term disability after gun injury: a cohort analysis, CMAJ Open, 10.9778/cmajo.20190200, 8, 3, (E469-E478), (2020).
  • Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis–Related, Child–Pugh A Cirrhosis, Clinical Gastroenterology and Hepatology, 10.1016/j.cgh.2020.04.083, (2020).
  • Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study, Journal of Immunotherapy, 10.1097/CJI.0000000000000334, 43, 8, (256), (2020).
  • Long-Term Clinical Outcomes of Intercalary Allograft Reconstruction for Lower-Extremity Bone Tumors, Journal of Bone and Joint Surgery, 10.2106/JBJS.18.00893, 102, 12, (1042-1049), (2020).
  • Axial cortical involvement of metastatic lesions to identify impending femoral fractures; a clinical validation study, Radiotherapy and Oncology, 10.1016/j.radonc.2019.10.007, 144, (59-64), (2020).
  • Regressive models for risk prediction of repeated multinomial outcomes: An illustration using Health and Retirement Study data, Biometrical Journal, 10.1002/bimj.201800101, 62, 4, (898-915), (2020).
  • The economic burden of kidney graft failure in the United States, American Journal of Transplantation, 10.1111/ajt.15750, 20, 5, (1323-1333), (2020).
  • Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis, Arthritis & Rheumatology, 10.1002/art.41153, 72, 3, (465-476), (2020).
  • Estimation in the Cox survival regression model with covariate measurement error and a changepoint, Biometrical Journal, 10.1002/bimj.201800085, 62, 5, (1139-1163), (2020).
  • Research Methods: Epidemiologic Research in Geriatric Oncology, Geriatric Oncology, 10.1007/978-3-319-57415-8, (1031-1042), (2020).
  • Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men, BMC Medical Research Methodology, 10.1186/s12874-020-0900-z, 20, 1, (2020).
  • Individual participant data meta‐analysis of intervention studies with time‐to‐event outcomes: A review of the methodology and an applied example, Research Synthesis Methods, 10.1002/jrsm.1384, 11, 2, (148-168), (2020).
  • Job duration and match characteristics over the business cycle, Review of Economic Dynamics, 10.1016/j.red.2020.01.003, (2020).
  • Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer, Cancer Medicine, 10.1002/cam4.2862, 9, 7, (2379-2389), (2020).
  • Competing risks analysis of the association between perioperative blood transfusion and long‐term outcomes after resection of colorectal cancer, Colorectal Disease, 10.1111/codi.14970, 22, 8, (871-884), (2020).
  • Geometric effect analysis of highway-rail grade crossing safety performance, Accident Analysis & Prevention, 10.1016/j.aap.2020.105470, 138, (105470), (2020).
  • The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study, BMC Medicine, 10.1186/s12916-020-1497-0, 18, 1, (2020).
  • Prospective assessment of loss to follow‐up: incidence and associated factors in a cohort of HIV‐positive adults in rural Tanzania, Journal of the International AIDS Society, 10.1002/jia2.25460, 23, 3, (2020).
  • On the relation between the cause‐specific hazard and the subdistribution rate for competing risks data: The Fine–Gray model revisited, Biometrical Journal, 10.1002/bimj.201800274, 62, 3, (790-807), (2020).
  • The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi‐state models to understand the dynamics of adherence, Pharmacoepidemiology and Drug Safety, 10.1002/pds.4995, 29, 5, (550-557), (2020).
  • Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non–muscle‐invasive bladder cancer (NMIBC): A cohort analysis, Cancer Medicine, 10.1002/cam4.3007, 9, 11, (4014-4025), (2020).
  • How soon do single mothers have another child? A competing risk analysis of second premarital childbearing in sub-Saharan African countries, BMC Pregnancy and Childbirth, 10.1186/s12884-020-2850-1, 20, 1, (2020).
  • Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2020.03.004, 122, (42-48), (2020).
  • Is there an association between social determinants and care dependency risk? A multi‐state model analysis of a longitudinal study, Research in Nursing & Health, 10.1002/nur.22022, 43, 3, (230-240), (2020).
  • Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction, European Journal of Cancer, 10.1016/j.ejca.2020.03.009, 132, (53-60), (2020).
  • The effect of adjuvant treatment in small node-negative HER2-positive breast cancer: which subgroup will benefit?, Clinical Breast Cancer, 10.1016/j.clbc.2020.05.012, (2020).
  • Association of diabetes with stroke and post‐stroke dementia: A population‐based cohort study, Alzheimer's & Dementia, 10.1002/alz.12101, 16, 7, (1003-1012), (2020).
  • Evaluating the effect of healthcare providers on the clinical path of heart failure patients through a semi-Markov, multi-state model, BMC Health Services Research, 10.1186/s12913-020-05294-3, 20, 1, (2020).
  • Modelling HIV disease process and progression in seroconversion among South Africa women: using transition-specific parametric multi-state model, Theoretical Biology and Medical Modelling, 10.1186/s12976-020-00128-5, 17, 1, (2020).
  • Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome, CNS Oncology, 10.2217/cns-2020-0009, 9, 2, (CNS53), (2020).
  • Multi-state analysis of hypertension and mortality: application of semi-Markov model in a longitudinal cohort study, BMC Cardiovascular Disorders, 10.1186/s12872-020-01599-7, 20, 1, (2020).
  • A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries, New England Journal of Medicine, 10.1056/NEJMoa2002183, 383, 2, (129-140), (2020).
  • A crash severity analysis at highway-rail grade crossings: The random survival forest method, Accident Analysis & Prevention, 10.1016/j.aap.2020.105683, 144, (105683), (2020).
  • Multistate models for examining the progression of intermittently-measured patient-reported symptoms among cancer patients: the importance of accounting for interval censoring, Journal of Pain and Symptom Management, 10.1016/j.jpainsymman.2020.07.012, (2020).
  • Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapies, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2020.06.016, 127, (9-18), (2020).
  • A Simultaneous Safety Analysis of Crash Frequency and Severity for Highway-Rail Grade Crossings: The Competing Risks Method, Journal of Advanced Transportation, 10.1155/2020/8878911, 2020, (1-13), (2020).
  • Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer, The Oncologist, 10.1634/theoncologist.2020-0161, 25, 8, (e1188-e1194), (2020).
  • Complement evasion strategies of Borrelia burgdorferi sensu lato, FEBS Letters, 10.1002/1873-3468.13894, 594, 16, (2645-2656), (2020).
  • Distribution of genetic variation underlying adult migration timing in steelhead of the Columbia River basin, Ecology and Evolution, 10.1002/ece3.6641, 10, 17, (9486-9502), (2020).
  • Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis, The Oncologist, 10.1634/theoncologist.2020-0085, 25, 8, (e1221-e1232), (2020).
  • Association of Programmed Death‐Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma Receiving Crizotinib, The Oncologist, 10.1634/theoncologist.2020-0088, 25, 8, (702-711), (2020).
  • How to Manage Febrile Neutropenia During the COVID Pandemic?, The Oncologist, 10.1634/theoncologist.2020-0285, 25, 8, (e1251-e1251), (2020).
  • KEYNOTE‐032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non‐Small Cell Lung Cancer, The Oncologist, 10.1634/theoncologist.2020-0067, 25, 8, (650-e1145), (2020).
  • Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801, The Oncologist, 10.1634/theoncologist.2020-0322, 25, 8, (e1146-e1157), (2020).
  • In Reply, The Oncologist, 10.1634/theoncologist.2020-0336, 25, 8, (e1259-e1259), (2020).
  • Invasion biology and uncertainty in native range definitions: response to Pereyra 2019, Conservation Biology, 10.1111/cobi.13528, 34, 4, (1041-1043), (2020).
  • Debate over the importance and meaning of native range in invasion biology: reply to Courchamp et al. , Conservation Biology, 10.1111/cobi.13529, 34, 4, (1044-1046), (2020).
  • Ensuring tests of conservation interventions build on existing literature, Conservation Biology, 10.1111/cobi.13555, 34, 4, (781-783), (2020).
  • Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study, The Oncologist, 10.1634/theoncologist.2020-0039, 25, 8, (e1158-e1169), (2020).
  • In Reply, The Oncologist, 10.1634/theoncologist.2020-0119, 25, 8, (e1255-e1256), (2020).
  • Misunderstandings of science and ethics in the moral panic over cats: reply to Crespin et al. 2020, Conservation Biology, 10.1111/cobi.13527, 34, 4, (1038-1040), (2020).
  • Hepatocellular Carcinoma in the COVID‐19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?, The Oncologist, 10.1634/theoncologist.2020-0416, 25, 8, (e1249-e1250), (2020).
  • Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study, The Lancet Respiratory Medicine, 10.1016/S2213-2600(20)30328-3, (2020).
  • Prognostic validation and treatment decision making of the 8th edition of the American Joint Committee on Cancer pathological staging system for elderly women with early-stage breast cancer, Aging, 10.18632/aging.103574, 12, 14, (15077-15090), (2020).
  • Liberalizing the killing of endangered wolves was associated with more disappearances of collared individuals in Wisconsin, USA, Scientific Reports, 10.1038/s41598-020-70837-x, 10, 1, (2020).
  • Analysing the Risk of Bankruptcy of Firms: Survival Analysis, Competing Risks and Multistate Models, Demography of Population Health, Aging and Health Expenditures, 10.1007/978-3-030-44695-6_25, (385-394), (2020).
  • Sample‐weighted semiparametric estimation of cause‐specific cumulative risk and incidence using left‐ or interval‐censored data from electronic health records, Statistics in Medicine, 10.1002/sim.8544, 39, 18, (2387-2402), (2020).
  • A behavioral economics‐based telehealth intervention to improve aspirin adherence following hospitalization for acute coronary syndrome, Pharmacoepidemiology and Drug Safety, 10.1002/pds.4988, 29, 5, (513-517), (2020).
  • Long‐term outcomes after perioperative treatment with omega‐3 fatty acid supplements in colorectal cancer, BJS Open, 10.1002/bjs5.50295, 4, 4, (678-684), (2020).
  • Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Coumarinylthiazolyl Iminothiazolidinone Hybrids as Potent Urease Inhibitors, ChemistrySelect, 10.1002/slct.202000429, 5, 18, (5387-5390), (2020).
  • 5‐Hydroxy‐isoxazolidine: A New Synthetic Approach to a Privileged Heterocycle for Organic Synthesis, ChemistrySelect, 10.1002/slct.202001337, 5, 18, (5367-5373), (2020).
  • Assessing the effects of beta‐blockers on pancreatic cancer risk: A nested case‐control study, Pharmacoepidemiology and Drug Safety, 10.1002/pds.4993, 29, 5, (599-604), (2020).
  • Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative, The Oncologist, 10.1634/theoncologist.2019-0977, 25, 8, (712-721), (2020).
  • Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan, Scientific Reports, 10.1038/s41598-020-71243-z, 10, 1, (2020).
  • Exit strategies of farmer co-operatives in the United States: A competing risks analysis, Journal of Co-operative Organization and Management, 10.1016/j.jcom.2020.100119, 8, 2, (100119), (2020).
  • Prognostic Factors for Short-term Recovery of Independence in a Multistate Model for Patients With a Hip Fracture, Journal of the American Medical Directors Association, 10.1016/j.jamda.2020.08.006, (2020).
  • Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma, World Journal of Surgical Oncology, 10.1186/s12957-020-02025-0, 18, 1, (2020).
  • Competing risks: Aims and methods, , 10.1016/bs.host.2019.11.001, (2020).
  • Modeling of spatio-temporally clustered survival HIV/AIDS data in the presence of competing risks setting, Spatial Statistics, 10.1016/j.spasta.2020.100460, 38, (100460), (2020).
  • Data monitoring committees for clinical trials evaluating treatments of COVID-19, Contemporary Clinical Trials, 10.1016/j.cct.2020.106154, 98, (106154), (2020).
  • State Occupation Probabilities in Non-Markov Models, Mathematical Methods of Statistics, 10.3103/S1066530719040033, 28, 4, (279-290), (2020).
  • The Association of Cognitive Impairment with Peritoneal Dialysis-Related Peritonitis, Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 10.3747/pdi.2018.00180, 39, 3, (229-235), (2020).
  • GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes, Clinical Chemistry, 10.1373/clinchem.2016.257212, 62, 12, (1612-1620), (2020).
  • Disengagement from mental health treatment and re-offending in those with psychosis: a multi-state model of linked data, Social Psychiatry and Psychiatric Epidemiology, 10.1007/s00127-020-01873-1, (2020).
  • Sequential Monte Carlo methods in Bayesian joint models for longitudinal and time-to-event data, Statistical Modelling, 10.1177/1471082X20916088, (1471082X2091608), (2020).
  • Surgical repair of parastomal bulging: a retrospective register‐based study on prospectively collected data, Colorectal Disease, 10.1111/codi.15197, 0, 0, (2020).
  • Applications of competing risks analysis in public health, Journal of the Korean Statistical Society, 10.1007/s42952-020-00058-5, (2020).
  • Palliative versus hospice care in patients with cancer: a systematic review, BMJ Supportive & Palliative Care, 10.1136/bmjspcare-2020-002195, (bmjspcare-2020-002195), (2020).
  • Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response, Cancers, 10.3390/cancers12082072, 12, 8, (2072), (2020).
  • On maximum likelihood estimation of competing risks using the cause-specific semi-parametric Cox model with time-varying covariates – An application to credit risk, Journal of the Operational Research Society, 10.1080/01605682.2020.1800418, (1-10), (2020).
  • Modeling dynamics in household car ownership over life courses: a latent class competing risks model, Transportation, 10.1007/s11116-019-10078-8, (2020).
  • Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2), PLOS ONE, 10.1371/journal.pone.0226724, 15, 1, (e0226724), (2020).
  • A Multi-population Approach to Forecasting All-Cause Mortality Using Cause-of-Death Mortality Data, North American Actuarial Journal, 10.1080/10920277.2019.1662316, (1-36), (2020).
  • Semiparametric regression and risk prediction with competing risks data under missing cause of failure, Lifetime Data Analysis, 10.1007/s10985-020-09494-1, (2020).
  • A Bayesian multi‐risks survival (MRS) model in the presence of double censorings, Biometrics, 10.1111/biom.13228, 0, 0, (2020).
  • Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score Analysis, CardioVascular and Interventional Radiology, 10.1007/s00270-020-02451-3, (2020).
  • Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study, BMJ, 10.1136/bmj.m1570, (m1570), (2020).
  • Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study, Acta Oncologica, 10.1080/0284186X.2020.1769858, (1-8), (2020).
  • A pseudo‐likelihood method for estimating misclassification probabilities in competing‐risks settings when true‐event data are partially observed, Biometrical Journal, 10.1002/bimj.201900198, 0, 0, (2020).
  • Estimation and inference for semi-competing risks based on data from a nested case-control study, Statistical Methods in Medical Research, 10.1177/0962280220926219, (096228022092621), (2020).
  • A Multi-State Approach to Modelling Intermediate Events and Multiple Mortgage Loan Outcomes, Risks, 10.3390/risks8020064, 8, 2, (64), (2020).
  • N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression, Leukemia, 10.1038/s41375-020-0940-8, (2020).
  • Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients, Transplant Infectious Disease, 10.1111/tid.13395, 0, 0, (2020).
  • Causal Inference in the Face of Competing Events, Current Epidemiology Reports, 10.1007/s40471-020-00240-7, (2020).
  • No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group, Leukemia & Lymphoma, 10.1080/10428194.2020.1786556, (1-10), (2020).
  • See more

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.